Diego A. Díaz García, Medical Oncologist, CEO and Founder at CánCare, shared a post on X about recent paper Quentin Dominique Thomas and colleagues authored:
“MSI/dMMR in NSCLC is rare (<1%) but has key implications for immunotherapy.
AI-powered NGS profiling reveals high TMB and MLH1/PMS2 loss in MSI+ lung tumors.
Precision diagnostics for better treatment decisions.”
Title: Artificial intelligence–driven microsatellite instability profiling reveals distinctive genetic features in patients with lung cancer
Authors: Quentin Dominique Thomas, Julie Adèle Vendrell, Lakhdar Khellaf, Sarah Cavaillon, Xavier Quantin, Jérôme Solassol, Simon Cabello-Aguilar
Read Full Article on ACS Journals.
Read about NSCLC on OncoDaily.